Clinical endings of subjects with chronic infection by Trypanosoma cruzi treated or not with agents

by Juan Carlos Villar
Published 2002-12-01

More and better systematic reviews for a best result in practice

by Juan Carlos Villar Centeno
Published 2000-04-01

Lack of systematic reviews in the Lstinoamerican biomedic literature: a case of Tripanocid threatment in Chagas' disease

by Olga Lucía Cortés, Juan Carlos Villar
Published 2000-08-01

Effect of Paper Surface Properties on Coated Paper Wettability with Different Fountain Solutions

by Nuria Gómez, Ester Quintana, Juan Carlos Villar
Published 2014-05-01

El proyecto “Cardiovascular Health Investigation and Collaboration to Assess the Markers and Outcomes of Chagas disease” (CHICAMOCHA): 15 años construyendo un activo institucional...

by Juan Carlos Villar-Centeno, MD., Esp., MSc., PhD
Published 2015-07-01

Estrategias y determinantes para recuperar participantes tras 12 años: cohorte CHICAMOCHA, Bucaramanga, Colombia

by Skarlet Marcell Vásquez, Victor Mauricio Herrera, Juan Carlos Villar
Published 2019-01-01

Treatment Patterns and their Relation to the Diagnosis of Chagas Disease in Patients with Heart Failure, 2001-2011: Bogotá, Colombia

by Micah Rae Pepper, Juan Guillermo Pérez, Juan Carlos Villar, Malcolm Bryant
Published 2013-03-01

Relación entre los atributos del sueño y el cambio en la presión arterial. Análisis de la cohorte CHICAMOCHA

by Jhon Edgar Vargas, Skarlet Marcell Vásquez, Juan Carlos Villar, Víctor Mauricio Herrera
Published 2019-07-01

Frequency of repositioning for preventing pressure ulcers in patients hospitalized in ICU: protocol of a cluster randomized controlled trial

by Olga L. Cortés, Mauricio Herrera-Galindo, Juan Carlos Villar, Yudi A. Rojas, María del Pilar Paipa, Luzdary Salazar
Published 2021-07-01

Fractionation of Pinus radiata wood by combination of steam explosion and organosolv delignification

by Camila María Imlauer-Vedoya, Priscila Vergara-Alarcón, María Cristina Area, Esteban Revilla, Fernando Esteban Felissia, Juan Carlos Villar
Published 2019-10-01

POSIBILIDADES DE LA INDUSTRIA AZUCARERA COMO BIORREFINERÍA MEDIANTE EL FRACCIONAMIENTO DE LA CAÑA DE AZÚCAR EN LA PRODUCCIÓN MÁS LIMPIA DE ETANOL

by Leyanis Mesa Garriga, Erenio González Suárez, Nancy López Bello, Cristóbal Cara Corpas, Eulogio Castro Galiano, Juan Carlos Villar Gutiérrez
Published 2009-04-01

¿Puede considerarse portadores asintomáticos a los donantes de sangre seropositivos para Trypanosoma cruzi?. Un estudio de validación en el proyecto CHICAMOCHA / Can Seropositive B...

by Juan Carlos Villar-Centeno, MD., Esp., MSc., PhD, Victor Mauricio Herrera-Galindo, MD., MSc., PhD, Agustín Vega, MD., Esp, Fernando Moso, MD., Esp
Published 2015-07-01

Association between emergency department length of stay and adverse perioperative outcomes in emergency surgery: a cohort study in two Colombian University hospitals

by Félix R. Montes, Skarlet Marcell Vásquez, Claudia Marcela Camargo-Rojas, Myriam V. Rueda, Lina Góez-Mogollón, Paula A. Alvarado, Danny J. Novoa, Juan Carlos Villar
Published 2019-04-01

Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis.

by Agustín Ciapponi, Fabiana Barreira, Lucas Perelli, Ariel Bardach, Joaquim Gascón, Israel Molina, Carlos Morillo, Nilda Prado, Adelina Riarte, Faustino Torrico, Isabela Ribeiro, Juan Carlos Villar, Sergio Sosa-Estani
Published 2020-08-01

Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study proto...

by Juan Carlos Villar, Víctor Mauricio Herrera, Juan Guillermo Pérez Carreño, Eliana Váquiro Herrera, Yeny Zulay Castellanos Domínguez, Skarlet Marcell Vásquez, Zulma Milena Cucunubá, Nilda Graciela Prado, Yolanda Hernández
Published 2019-08-01

Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a rando...

by Juan Carlos Villar, Víctor Mauricio Herrera, Juan Guillermo Pérez Carreño, Eliana Váquiro Herrera, Yeny Zulay Castellanos Domínguez, Skarlet Marcell Vásquez, Zulma Milena Cucunubá, Nilda Graciela Prado, Yolanda Hernández
Published 2019-07-01

Capacidad discriminatoria y concordancia entre el ELISA-F29 y la PCR en individuos con infección por T. cruzi / Discriminatory Power and Concordance between ELISA-F29 and PCR in In...

by Edgar David Gómez-Laitón, MD., Laura Andrea Polo-Ardila, Enf., Yeny Zulay Castellanos-Domínguez, Bact., Esp., MsC, Víctor Mauricio Herrera-Galindo, MD., MSc., PhD., Juan Carlos Villar-Centeno, MD., Esp., Msc., PhD.
Published 2015-07-01

¿Puede asociarse el sedentarismo con hallazgos clínicos de alarma de enfermedad crónica en adultos jóvenes?. Un análisis en el proyecto CHICAMOCHA / Can Sedentarism be Associated w...

by Juan Carlos Villar-Centeno, MD., Esp., MsC., PhD., Víctor Mauricio Herrera-Galindo, MD., MsC., PhD., Karen Julieth Moreno-Medina, Fist., Esp., Yeny Zulay Castellanos-Domínguez, Luz Ximena Martínez-Contreras, MD.Nutri y Diet, Olga Lucía Cortés, Enf,. Esp., Mg., PhD
Published 2015-07-01

“Cardiovascular Health Investigation and Collaboration to Assess the Markers and Outcomes of Chagas disease” (CHICAMOCHA): Concepto, métodos y características de una cohorte de don...

by Juan Carlos Villar-Centeno, MD., Esp., MSc., PhD., Víctor Mauricio Herrera-Galindo, MD., MSc., PhD, Ángel María Chávez-Neira, MD., Esp, Luz Ximena Martínez-Contreras, MD., Nut y Diet., Luis Ángel Villar-Centeno, MD., Esp.,. MSc, Elizabeth Ardila, MD., Esp, Skarlet Marcell Vásquez, Enf., MSc., Martha Vásquez, Enf.
Published 2015-07-01